000 03286cam a2200397Ii 4500
001 95253
003 ES-MaUEC
005 20230102112654.0
006 m o d
007 cr cnu---unuuu
008 170124s2017 sz a ob 001 0 eng d
020 _a3319427695
_q(electronic bk.)
020 _a9783319427690
_q(electronic bk.)
020 _z3319427687
020 _z9783319427683
_q(print)
035 _a(OCoLC)969844116
_z(OCoLC)970391198
_z(OCoLC)970609997
_z(OCoLC)970792278
_z(OCoLC)971040747
_z(OCoLC)971081072
_z(OCoLC)971221521
_z(OCoLC)971347847
_z(OCoLC)974651699
_z(OCoLC)981776814
_z(OCoLC)1005811408
_z(OCoLC)1011989489
040 _aGW5XE
_cGW5XE
_dGW5XE
_dOCLCO
_dN$T
_dEBLCP
_dUAB
_dNJR
_dYDX
_dUPM
_dOCLCO
_dIOG
_dOCLCO
_dMERER
_dESU
_dZ5A
_dOCLCO
_dJBG
_dIAD
_dOCLCO
_dICW
_dOCLCO
_dICN
_dOCLCQ
_dOCLCO
_dOTZ
_dOCLCQ
_dVT2
_dOCLCO
_dOCLCQ
_dU3W
_dOCLCO
_dOCLCA
_dES-MaUEC
_bspa
050 4 _aRC280.P7
_b2017 EB
245 0 0 _aManagement of prostate cancer :
_ba multidisciplinary approach
_cMichel Bolla, Hendrik van Poppel, editors.
250 _aSecond edition.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea (viii, 422 páginas)
_bilustraciones
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
504 _aIncluye referencias bibliográficas e índice
505 0 _aEpidemiology of prostate cancer in Europe -- Chemoprevention -- Individual and mass screening -- Anatomo-pathology -- Biology -- Genomics -- Radiologic investigations(multiparametric MRI, whole body MRI) -- Nuclear Medecine: follow-up (Choline PET-CT, Radium 223)and treatment of bone metastases -- Diagnosis, clinical work up, TNM classification Markers -- Active surveillance -- Open Radical Prostatectomy -- The robotic laparoscopic radical prostatectomy -- Brachytherapy (Low dose rate) -- Brachytherapy (High dose rate) -- IMRT, hypofractionated irradiation and stereotactic irradiation -- External irradiation + androgen suppression -- Post-operative irradiation: immediate or early delayed?- High Intensity Focused Ultrasound -- Cryotherapy -- Follow-up after radical treatments* and relapse -- First line hormonal manipulations -- Upfront chemotherapy at initiation of hormonal treatment for metastatic prostate cancer -- Bone-targeted therapies (Bisphosphonates, denosumab and Radium 223 -- Targeted therapies and vaccination -- How to interprete results -- Prostate EAU guidelines -- Better Patients perspective.
520 3 _aThis exhaustive review of prostate cancer management covers epidemiology, biology, chemoprevention, screening and diagnosis, therapies including surgery, radiation, high-intensity ultrasound, cryotherapy, and more. Includes up-to-date clinical trial data.
650 7 _aPróstata
_xCáncer
_2embne
_0(OCoLC)fst01079496
_0
_9182337
700 1 _aBolla, M.,
_eeditor literario
700 1 _aPoppel, Hendrik van,
_eeditor literario
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-42769-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c95253
_d95253
_x1